Charles Hugh-Jones
Chief Executive Officer bij Volastra Therapeutics, Inc.
Profiel
Charles Hugh-Jones is currently the Chief Executive Officer at Volastra Therapeutics, Inc. He was previously the Chief Medical Officer at Allergan Ltd.
(Ireland) from 2018 to 2020.
Prior to that, he worked at Addleshaw Booth & Co. from 2004 to 2007.
Actieve functies van Charles Hugh-Jones
Bedrijven | Functie | Begin |
---|---|---|
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Chief Executive Officer | - |
Eerdere bekende functies van Charles Hugh-Jones
Bedrijven | Functie | Einde |
---|---|---|
ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 08-05-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |